At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant

At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant

Plasma samples taken at different time points from donors who received either AstraZeneca (Vaxzevria) or Pfizer (Comirnaty) or Moderna (Spikevax) coronavirus disease-19 (COVID-19) vaccine were assessed in virus neutralization assays against Delta and Omicron variants of concern and a reference isola...

Full description

Bibliographic Details
Main Authors: Nagendrakumar B. Singanallur, Petrus Jansen van Vuren, Alexander J. McAuley, Matthew P. Bruce, Michael J. Kuiper, Stella M. Gwini, Shane Riddell, Sarah Goldie, Trevor W. Drew, Kim R. Blasdell, Mary Tachedjian, Shruthi Mangalaganesh, Simran Chahal, Leon Caly, Julian D. Druce, Jennifer A. Juno, Stephen J. Kent, Adam K. Wheatley, Seshadri S. Vasan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Immunology
Subjects:
AlphaFold
biomolecular modelling
COVID-19
neutralising antibody titres
SARS-CoV-2
spike protein
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.883612/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.883612/full

Similar Items